Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cantaloupe (CTLP) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Cantaloupe (CTLP) over the last 15 years, with Sep 2025 value amounting to $55.0 million.

  • Cantaloupe's Cash & Equivalents rose 66.00% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year increase of 66.00%. This contributed to the annual value of $51.1 million for FY2025, which is 13.19% down from last year.
  • Cantaloupe's Cash & Equivalents amounted to $55.0 million in Q3 2025, which was up 7.51% from $51.1 million recorded in Q2 2025.
  • In the past 5 years, Cantaloupe's Cash & Equivalents ranged from a high of $88.6 million in Q1 2021 and a low of $27.7 million during Q4 2024.
  • In the last 3 years, Cantaloupe's Cash & Equivalents had a median value of $50.2 million in 2024 and averaged $47.1 million.
  • As far as peak fluctuations go, Cantaloupe's Cash & Equivalents spiked by 242.02% in 2021, and later crashed by 63.12% in 2022.
  • Over the past 5 years, Cantaloupe's Cash & Equivalents (Quarterly) stood at $76.3 million in 2021, then plummeted by 63.12% to $28.1 million in 2022, then spiked by 54.49% to $43.5 million in 2023, then slumped by 36.34% to $27.7 million in 2024, then soared by 66.00% to $55.0 million in 2025.
  • Its Cash & Equivalents was $55.0 million in Q3 2025, compared to $51.1 million in Q2 2025 and $46.3 million in Q1 2025.